ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

Why Breast Neoplasms is on this study

  • ClinicalTrials.gov files the study under Breast Neoplasms.
  • GPT-6.1 Sol (High) judged the term right: what the study is about. Oct 19 (day only)
  • It is the study's main condition, by the main-condition rule: the study is compared with others under Breast Neoplasms.
1 links0 made here, not in the record2 judgments2 judges (the rules as one: Rule based)0 record changes seen
GPT-6.1 Sol (High)Rule based
Oct 19Oct 26Nov 2Nov 9Nov 16Nov 23TodayNCT03275311Evolution of theTherapeutic Care inMetastatic Breast CancerFrom 2008UNICANCERrecruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSBreast NeoplasmsThe registry's MeSH filing›Oct 19 · GPT-6.1 Sol (High) · RightAs of now · Rule based · Main conditionMain condition

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

All judgments on this study

WhenLinkJudgeDecisionState
Oct 19Breast NeoplasmsGPT-6.1 Sol (High)RightCurrent
As of nowBreast NeoplasmsRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.